Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision label changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-22T08:33:30.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T06:32:19.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added announcing a transition from using “Artificial Intelligence” to “Super Intelligence” in some federal-agency content.
    Difference
    0.5%
    Check dated 2026-10-25T06:58:16.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T05:46:22.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T08:31:25.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The history now lists a new version (v3.7.0) and removes the previous (v3.6.6), representing an update to the recorded history rather than a change to the trial data.
    Difference
    0.1%
    Check dated 2026-09-20T03:26:18.000Z thumbnail image

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.